WCN26-4926 Tosufloxacin-induced Nephrogenic Diabetes Insipidus in an Infant: A Case Report

Read full text Summarise with VIRAT
Authors: Shogo Kato, Shoji Tsuji, Yuri Fukui, Taichi Ohmachi, Rino Morikawa, Yoshihiro Fushimi, Shohei Akagawa, Sosaku Yamanouchi, Kazunari Kaneko
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Tosufloxacin (TFLX), a fluoroquinolone antibiotic approved for pediatric use in Japan, is primarily prescribed for macrolide-resistant Mycoplasma pneumoniae infections. While effective, TFLX-associated renal complications have been reported, particularly in infants. We present a rare case of TFLX-induced crystalline nephropathy that manifests transient nephrogenic diabetes insipidus (NDI).

Fields of Study & Subjects

Acute Kidney Injury Research Nephrotoxicity and Medicinal Plants Chemotherapy-induced organ toxicity mitigation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103980–103980
Publication date
25 March 2026
Language
EN